1. Home
  2. BZH vs ELVN Comparison

BZH vs ELVN Comparison

Compare BZH & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BZH
  • ELVN
  • Stock Information
  • Founded
  • BZH 1985
  • ELVN 2016
  • Country
  • BZH United States
  • ELVN United States
  • Employees
  • BZH N/A
  • ELVN N/A
  • Industry
  • BZH Homebuilding
  • ELVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BZH Consumer Discretionary
  • ELVN Health Care
  • Exchange
  • BZH Nasdaq
  • ELVN Nasdaq
  • Market Cap
  • BZH 870.3M
  • ELVN 1.0B
  • IPO Year
  • BZH 1994
  • ELVN 2020
  • Fundamental
  • Price
  • BZH $22.12
  • ELVN $21.60
  • Analyst Decision
  • BZH Strong Buy
  • ELVN Strong Buy
  • Analyst Count
  • BZH 3
  • ELVN 5
  • Target Price
  • BZH $39.67
  • ELVN $37.80
  • AVG Volume (30 Days)
  • BZH 387.4K
  • ELVN 269.1K
  • Earning Date
  • BZH 01-30-2025
  • ELVN 03-13-2025
  • Dividend Yield
  • BZH N/A
  • ELVN N/A
  • EPS Growth
  • BZH N/A
  • ELVN N/A
  • EPS
  • BZH 3.93
  • ELVN N/A
  • Revenue
  • BZH $2,412,332,000.00
  • ELVN N/A
  • Revenue This Year
  • BZH $20.29
  • ELVN N/A
  • Revenue Next Year
  • BZH $14.20
  • ELVN N/A
  • P/E Ratio
  • BZH $5.62
  • ELVN N/A
  • Revenue Growth
  • BZH 12.27
  • ELVN N/A
  • 52 Week Low
  • BZH $20.66
  • ELVN $10.90
  • 52 Week High
  • BZH $38.22
  • ELVN $30.03
  • Technical
  • Relative Strength Index (RSI)
  • BZH 24.77
  • ELVN 47.03
  • Support Level
  • BZH $20.66
  • ELVN $20.40
  • Resistance Level
  • BZH $28.08
  • ELVN $22.42
  • Average True Range (ATR)
  • BZH 1.05
  • ELVN 1.25
  • MACD
  • BZH -0.56
  • ELVN 0.06
  • Stochastic Oscillator
  • BZH 9.78
  • ELVN 59.59

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

Share on Social Networks: